Proteome Sciences (LON:PRM) Releases Quarterly Earnings Results

Proteome Sciences (LON:PRM – Get Free Report) announced its earnings results on Wednesday. The company reported GBX (0.41) EPS for the quarter, Digital Look Earnings reports. Proteome Sciences had a positive return on equity of 33.80% and a negative net margin of 81.50%.

Proteome Sciences Stock Performance

Shares of LON PRM traded down GBX 0.19 during trading on Wednesday, hitting GBX 1.26. The company had a trading volume of 534,540 shares, compared to its average volume of 374,873. The stock has a 50 day simple moving average of GBX 1.72 and a 200 day simple moving average of GBX 1.64. The company has a debt-to-equity ratio of -165.46, a quick ratio of 0.37 and a current ratio of 0.13. Proteome Sciences has a 12 month low of GBX 1.11 and a 12 month high of GBX 4.40. The firm has a market capitalization of £4.42 million, a P/E ratio of -1.21 and a beta of 0.16.

Get Proteome Sciences alerts:

Proteome Sciences Company Profile

(Get Free Report)

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.

Featured Stories

• Five stocks we like better than Proteome Sciences
• Jackson’s Record Quarter Powers the Bull Case
• Holiday Shopping Is Almost Here—And Target May Be Ready to Win Big
• AI Panic Hit Tech Stocks—But NVIDIA’s Growth Engine Is Intact
• 5 Buy-and-Hold Stocks Built to Weather a Volatile Market

Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.